BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6287530)

  • 1. Alterations of synaptic high and low affinity opiate binding sites after acute and chronic morphine administration in mice.
    Sivam SP; Nabeshima T; Ho IK
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(2):119-27. PubMed ID: 6287530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo binding of naloxone to opioid receptors in morphine-dependent mice.
    Oishi R; Ozaki M; Takemori AE
    Neuropharmacology; 1983 Aug; 22(8):1015-9. PubMed ID: 6312358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of opiate receptors in the brain and spinal cord of morphine tolerant mice].
    Patkina NA; Zvartau EE; Rozhanets VV; Malin KM; Kiriakov GV
    Biull Eksp Biol Med; 1986 Sep; 102(9):296-8. PubMed ID: 3019449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain.
    Brase DA; Han YH; Dewey WL
    Diabetes; 1987 Oct; 36(10):1173-7. PubMed ID: 2820820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
    Abdelhamid EE; Takemori AE
    Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced affinity of opiate receptors for naloxone in striatal slices of morphine-dependent mice.
    Kitano T; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):341-51. PubMed ID: 199923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats.
    Davis ME; Akera T; Brody TM
    J Pharmacol Exp Ther; 1979 Oct; 211(1):112-9. PubMed ID: 226669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo opiate binding unchanged in tolerant/dependent mice.
    Dum J; Meyer G; Höllt V; Herz A
    Eur J Pharmacol; 1979 Oct; 58(4):453-60. PubMed ID: 574455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between incorporation of choline into phosphatidylcholine and morphine binding sites.
    Natsuki R
    Arukoru Kenkyuto Yakubutsu Ison; 1992 Feb; 27(1):57-70. PubMed ID: 1317702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific accumulation of dihydromorphine and naltrexone by corpus striatal slices of morphine-dependent mice.
    Oishi R; Takemori AE
    Neuropharmacology; 1982 Jan; 21(1):57-61. PubMed ID: 6278352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine tolerance is associated with elevated levels of an uncharacterized endorphin (peak B) in mouse brain with no change in 3H-dihydromorphine binding.
    Lipman JJ; Miller BE; Karkara S; Winfield RC; North WC; Byrne WL
    Life Sci; 1983; 33 Suppl 1():373-6. PubMed ID: 6319893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states.
    Geary WA; Wooten GF
    Brain Res; 1985 Dec; 360(1-2):214-23. PubMed ID: 4075170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of morphine dependence and abstinence on opioid receptors in the cerebral cortex and spinal cord of the rat.
    Antkiewicz-Michaluk L; Michaluk J; Marona-Lewicka D; Vetulani J
    Pol J Pharmacol Pharm; 1988; 40(1):11-6. PubMed ID: 2853335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsomal opiate receptors: characterization of smooth microsomal and synaptic membrane opiate receptors.
    Roth BL; Coscia CJ
    J Neurochem; 1984 Jun; 42(6):1677-84. PubMed ID: 6327910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.
    Ulibarri I; García-Sevilla JA; Ugedo L
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):530-7. PubMed ID: 2830545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN; Das S; Bansinath M; Prasad R
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
    Kovács GL; Acsai L; Tihanyi A; Telegdy G
    Eur J Pharmacol; 1983 Sep; 93(3-4):149-58. PubMed ID: 6685650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.